Intelicanna Ltd (INTL) - Cash Flow Conversion Efficiency

Latest as of December 2022: -0.025x

Based on the latest financial reports, Intelicanna Ltd (INTL) has a cash flow conversion efficiency ratio of -0.025x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-194.89 Million ≈ $-522.48K USD) by net assets (ILA7.77 Billion ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Intelicanna Ltd - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Intelicanna Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Intelicanna Ltd for a breakdown of total debt and financial obligations.

Intelicanna Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intelicanna Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Intrasense PA:ALINS	0.452x
GlycoMimetics Inc NASDAQ:GLYC	-1.513x
Logismos Information Systems S.A AT:LOGISMOS	0.026x
G.M. LEATHER S.P.A. F:N78	N/A
Ostin Technology Group Co Ltd NASDAQ:OST	-0.096x
Radiant Utama Interinsco Tbk JK:RUIS	-0.070x
Scandinavian ChemoTech AB Series B ST:CMOTEC-B	-0.550x
Globe Kita Terang Tbk PT JK:GLOB	-0.003x

Annual Cash Flow Conversion Efficiency for Intelicanna Ltd (2012–2022)

The table below shows the annual cash flow conversion efficiency of Intelicanna Ltd from 2012 to 2022. For the full company profile with market capitalisation and key ratios, see INTL stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	ILA7.77 Billion ≈ $20.84 Million	ILA-286.06 Million ≈ $-766.91K	-0.037x	-166.91%
2021-12-31	ILA6.78 Billion ≈ $18.17 Million	ILA372.78 Million ≈ $999.41K	0.055x	+110.63%
2020-12-31	ILA7.04 Billion ≈ $18.88 Million	ILA-3.64 Billion ≈ $-9.77 Million	-0.518x	-2543.55%
2019-12-31	ILA8.07 Billion ≈ $21.64 Million	ILA-158.05 Million ≈ $-423.74K	-0.020x	+91.86%
2018-12-31	ILA7.19 Billion ≈ $19.28 Million	ILA-1.73 Billion ≈ $-4.64 Million	-0.240x	-63.55%
2017-12-31	ILA6.87 Billion ≈ $18.42 Million	ILA-1.01 Billion ≈ $-2.71 Million	-0.147x	-581.67%
2016-12-31	ILA5.99 Billion ≈ $16.07 Million	ILA182.92 Million ≈ $490.39K	0.031x	+106.88%
2015-12-31	ILA4.91 Billion ≈ $13.17 Million	ILA-2.18 Billion ≈ $-5.84 Million	-0.444x	+24.51%
2014-12-31	ILA4.89 Billion ≈ $13.12 Million	ILA-2.88 Billion ≈ $-7.71 Million	-0.588x	-1336.24%
2013-12-31	ILA4.41 Billion ≈ $11.84 Million	ILA-180.63 Million ≈ $-484.25K	-0.041x	+58.50%
2012-12-31	ILA33.29 Billion ≈ $89.24 Million	ILA-3.28 Billion ≈ $-8.80 Million	-0.099x	--

About Intelicanna Ltd

TA:INTL Israel Drug Manufacturers - Specialty & Generic

Market Cap

$10.11 Million

ILA3.77 Billion ILA

Market Cap Rank

#26846 Global

#389 in Israel

Share Price

ILA80.30

Change (1 day)

+0.37%

52-Week Range

ILA45.50 - ILA114.90

All Time High

ILA11460.00